1208688004: Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)

• SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...
• \Medicinal product categorized by disposition (product)\Product containing peroxisome proliferator-activated receptor agonist (product)\Product containing thiazolidinedione (product)\Product containing pioglitazone (medicinal product)\Product containing alogliptin and pioglitazone (medicinal product)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)
• \Medicinal product categorized by disposition (product)\Product containing peroxisome proliferator-activated receptor agonist (product)\Product containing thiazolidinedione (product)\Product containing pioglitazone (medicinal product)\Product containing pioglitazone in oral dose form (medicinal product form)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)
• \Medicinal product categorized by disposition (product)\Product containing peroxisome proliferator-activated gamma receptor agonist (product)\Product containing thiazolidinedione (product)\Product containing pioglitazone (medicinal product)\Product containing alogliptin and pioglitazone (medicinal product)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)
• \Medicinal product categorized by disposition (product)\Product containing peroxisome proliferator-activated gamma receptor agonist (product)\Product containing thiazolidinedione (product)\Product containing pioglitazone (medicinal product)\Product containing pioglitazone in oral dose form (medicinal product form)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)
• \Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing hydrolase inhibitor (product)\Product containing peptide hydrolase inhibitor (product)\Product containing dipeptidyl peptidase IV inhibitor (product)\Product containing alogliptin (medicinal product)\Product containing alogliptin and pioglitazone (medicinal product)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)
• \Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing hydrolase inhibitor (product)\Product containing peptide hydrolase inhibitor (product)\Product containing dipeptidyl peptidase IV inhibitor (product)\Product containing alogliptin (medicinal product)\Product containing alogliptin in oral dose form (medicinal product form)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)
• \Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing pyrimidine (product)\Product containing alogliptin (medicinal product)\Product containing alogliptin and pioglitazone (medicinal product)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)
• \Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing pyrimidine (product)\Product containing alogliptin (medicinal product)\Product containing alogliptin in oral dose form (medicinal product form)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)
• \Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing thiazole (product)\Product containing thiazolidinedione (product)\Product containing pioglitazone (medicinal product)\Product containing alogliptin and pioglitazone (medicinal product)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)
• \Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing thiazole (product)\Product containing thiazolidinedione (product)\Product containing pioglitazone (medicinal product)\Product containing pioglitazone in oral dose form (medicinal product form)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)
• \Product manufactured as oral dose form (product)\Product containing pioglitazone in oral dose form (medicinal product form)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)
• \Product manufactured as oral dose form (product)\Product containing alogliptin in oral dose form (medicinal product form)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Mar 2022. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
4970511019	Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4970512014	Alogliptin- and pioglitazone-containing product in oral dose form	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core

Expanded Value Set

This concept is not in any reference sets

Back to Start